Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) stock suffered a major decline of -13.5% on 1/10/25. The shares closed at $3.96. However, this decline was accompanied by below average trading volume at 81% of normal. The stock has been extremely weak relative to the market over the last nine months and has declined -10.6% during the last week.
Current PriceTarget Research Rating
Ironwood Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment